FIL Foundation About

About us

The Italian Lymphoma Foundation is an NPO which coordinates the activities carried out in Italy in the field of lymphoma by more than 120 centers located throughout the country. Our aim is improving the centers skills in terms of research and assistance. FIL conducts scientific research activities in the field of lymphoma and, as a non-profit organization, its purposes only concern social solidarity.The Italian Lymphoma Foundation has been the natural evolution of the Italian Lymphoma Intergroup, which was founded in 1993 with the first meeting held in Florence as a group of spontaneous cooperation between clinicians and Italian researchers involved in the study and treatment of lymphoma. Its existence and its assets were later formalized in July 2004 with a notary deed that led to the creation of a foundation with legal status and to the enrolment in the register of NPOs. The Italian Lymphoma Foundation was born with the aim of make active groups in the study of lymphoma cooperate; afterwards groups have merged and the IIL has decided to become a reference point for their cooperation. FIL Onlus was born in Alessandria on September 30, 2010 with a notarial deed that has marked the transformation of the statute, with the fusion of all groups within one large organization. FIL  encourages prospective and retrospective studies in order to answer questions that require a large case report. Therefore it intends to foster partnerships with international organizations, to which it is configured as a partner of choice. FIL also seeks to organize and improve services for the diagnosis and treatment of other lymphoproliferative disorders and promotes the formation of the Italian Registry of lymphoma (RIL). FIL Onlus develops projects for the diffusion of information on lymphoma, in order to raise the awareness of the problem and help patients and relatives; coordinate research groups in the fight against lymphoma; constitute the scientific, organizational and legal framework for managing clinical trials on lymphoma; coordinate the efforts of researchers to create one large Italian cooperative group for the fight against lymphoma and collaborate with European groups as for international studies on lymphoma. FIL Onlus cooperates with the International Extranodal Lymphoma Study Group (IELSG). Other studies on international prognostic factors are in progress and FIL is the promoter (F2, T-cell project, early-PET validation); new collaborations with the European Organisation for Research and Treatment of Cancer (EORTC) for localized Hodgkin and with Mantle Cell Network for the mantle lymphoma have started.